The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Severe Hypoglycemia and Risks of Vascular Events and Death
Open accessAbstract
BACKGROUND: Severe hypoglycemia may increase the risk of a poor outcome in patients with type 2 diabetes assigned to an intensive glucose-lowering intervention. We analyzed data from a large study of intensive glucose lowering to explore the relationship between severe hypoglycemia and adverse clinical outcomes. METHODS: We examined the associations between severe hypoglycemia and the risks of macrovascular or microvascular events and death among 11,140 patients with type 2 diabetes, using Cox proportional-hazards models with adjustment for covariates measured at baseline and after randomization. RESULTS: During a median follow-up period of 5 years, 231 patients (2.1%) had at least one severe hypoglycemic episode; 150 had been assigned to intensive glucose control (2.7% of the 5571 patients in that group), and 81 had been assigned to standard glucose control (1.5% of the 5569 patients in that group). The median times from the onset of severe hypoglycemia to the first major macrovascular event, the first major microvascular event, and death were 1.56 years (interquartile range, 0.84 to 2.41), 0.99 years (interquartile range, 0.40 to 2.17), and 1.05 years (interquartile range, 0.34 to 2.41), respectively. During follow-up, severe hypoglycemia was associated with a significant increase in the adjusted risks of major macrovascular events (hazard ratio, 2.88; 95% confidence interval [CI], 2.01 to 4.12), major microvascular events (hazard ratio, 1.81; 95% CI, 1.19 to 2.74), death from a cardiovascular cause (hazard ratio, 2.68; 95% CI, 1.72 to 4.19), and death from any cause (hazard ratio, 2.69; 95% CI, 1.97 to 3.67) (P<0.001 for all comparisons). Similar associations were apparent for a range of nonvascular outcomes, including respiratory, digestive, and skin conditions (P<0.01 for all comparisons). No relationship was found between repeated episodes of severe hypoglycemia and vascular outcomes or death. CONCLUSIONS: Severe hypoglycemia was strongly associated with increased risks of a range of adverse clinical outcomes. It is possible that severe hypoglycemia contributes to adverse outcomes, but these analyses indicate that hypoglycemia is just as likely to be a marker of vulnerability to such events. (Funded by Servier and the National Health and Medical Research Council of Australia; ClinicalTrials.gov number, NCT00145925.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the frequency of severe hypoglycemia in these trials was 2 to 3 times higher in the intensive therapy groups”
From Targets for Glycemic Control (2018) · cites this paper as [31]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In people with type 2 diabetes and established, or very high risk for, cardiovascular disease (CVD), there is a clear association between an increased mortality and severe hypoglycemia (62,63) and symptomatic hypoglycemia (64).”
From Hypoglycemia (2018) · cites this paper as [63]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Post hoc analysis of clinical trials examining the effects of strict glycemic control on cardiovascular outcomes showed that exposure to severe hypoglycemia was strongly associated with a range of adverse outcomes, including death (2, 3).”
From Effect of Hypoglycemia on QT Interval in Individuals With and Without Type 2 Diabetes: A Randomized Crossover Trial (2025) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“In ADVANCE, where rates of hypoglycemia were low, a similar pattern was found (47).”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [47]
The cited source says what the claim attributes to it.
In the citing paper
“a higher mortality was reported in participants with 1 or more episodes of severe hypoglycemia in the ACCORD (30), ADVANCE (31) and VADT trials (25), irrespective of the different treatment arms in which individual participants were allocated.”
From Targets for Glycemic Control (2018) · cites this paper as [31]
The cited source says what the claim attributes to it.
In the citing paper
“An association of level 3 hypoglycemia with mortality was also found in the ADVANCE trial and in clinical practice (77,78).”
From 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. (2026) · cites this paper as [77]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“U500 regular insulin (contains 500 units/mL of regular insulin) may improve glycemia in the therapy of persons with DM who have severe insulin resistance (eg, require >200 total units of insulin/day).1102–1105”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1105]
Experimental — accuracy not yet measuredIn the citing paper
“multiple studies have shown a strong relationship between hypoglycemia (severe or not severe) and cardiovascular events and mortality”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [197]
In the citing paper
“All three trials clearly demonstrated that an episode of severe hypoglycemia was associated with an increased risk of subsequent mortality.”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [47]
In the citing paper
“In ADVANCE, where rates of hypoglycemia were low, a similar pattern was found (47).”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [47]
In the citing paper
“An association of level 3 hypoglycemia with mortality was also found in the ADVANCE trial (90).”
From 6. Glycemic Targets: Standards of Care in Diabetes—2023 (2023) · cites this paper as [90]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Rovere, M. T. L., Bigger, J. T., Marcus, F. I., Mortara, A., & Schwartz, P. J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11144-8 · Cited by 3,120
Patel, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61303-8 · Cited by 2,054
Self-citationIntensive glucose control and macrovascular outcomes in type 2 diabetes
Turnbull, F. M., Abraira, C., Anderson, R. J., Byington, R. P., Chalmers, J. P., Duckworth, W. C., Evans, G. W., Gerstein, H. C., Holman, R. R., Moritz, T. E., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1470-0 · Cited by 1,189
Self-citationGerstein, H. C., Miller, M., & Byington, R. P. (2010) · Cited by 981
Bonds, D. E., Miller, M. E., Bergenstal, R. M., Buse, J. B., Byington, R. P., Cutler, J. A., Dudl, R. J., Ismail-Beigi, F., Kimel, A. R., Hoogwerf, B., et al. (2010) · BMJ · doi:10.1136/bmj.b4909 · Cited by 933
Research works printed but not linked: 3
- Therneau TM, Grambsch PM. Modelling survival data: extending the Cox model. New York: Springer, 2000.
- Hoekstra JBL, 2009, Diabetologia, 52, 237
- Miller ME, 2009, Diabetologia, 52, 63
Cited by
Sorted by citations
Items 201–300 of 1,002
Hong, E. S., Khang, A. R., Yoon, J. W., Kang, S. M., Choi, S. H., Park, K. S., Jang, H. C., Shin, H., Walford, G. A., & Lim, S. K. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01600.x · Cited by 77
Standl, E., Stevens, S. R., Armstrong, P. W., Buse, J. B., Chan, J. C. N., Green, J. B., Lachin, J. M., Scheen, A., Travert, F., Van de Werf, F., et al. (2018) · Diabetes Care · doi:10.2337/dc17-1778 · Cited by 76
McCoy, R. G., Van Houten, H. K., Ziegenfuss, J. Y., Shah, N. D., Wermers, R. A., & Smith, S. A. (2013) · Endocrine Practice · doi:10.4158/ep12382.or · Cited by 76
Hypoglycemia, Chronic Kidney Disease, and Diabetes Mellitus
Alsahli, M., & Gerich, J. E. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.07.013 · Cited by 81
Pistrosch, F., Ganz, X., Bornstein, S. R., Birkenfeld, A. L., Henkel, E., & Hanefeld, M. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0727-y · Cited by 79
Andersson, C., Gaal, L. V., Caterson, I. D., Weeke, P. E., James, W. P. T., Couthino, W., Finer, N., Sharma, A. M., Maggioni, A. P., & Torp-Pedersen, C. T. (2012) · Diabetologia · doi:10.1007/s00125-012-2584-3 · Cited by 77
Risk Factors and Adverse Outcomes of Severe Hypoglycemia in Type 2 Diabetes Mellitus
Yun, J., & Ko, S. (2016) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2016.40.6.423 · Cited by 77
The ORIGIN Trial Investigators (2015) · Diabetes Care · doi:10.2337/dc14-1329 · Cited by 75
Hypoglycemia after antimicrobial drug prescription for older patients using sulfonylureas
Parekh, T. M., Raji, M., Lin, Y.-L., Tan, A., Kuo, Y.-F., & Goodwin, J. S. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.3293 · Cited by 75
Substantial Increase in Incidence of Severe Hypoglycemia Between 1997–2000 and 2007–2010
Holstein, A., Patzer, O. M., Machalke, K., Holstein, J. D., Stümvoll, M., & Kovacs, P. L. (2012) · Diabetes Care · doi:10.2337/dc11-1470 · Cited by 75
Morgan, C. L., Mukherjee, J., Jenkins‐Jones, S., Holden, S. E., & Currie, C. J. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12306 · Cited by 77
Mosley, J., Smith, L., Everton, E. C., & Fellner, C. (2015) · PubMed Central · Cited by 75
Medical management of diabetic retinopathy: fenofibrate and ACCORD Eye studies
Wright, A. D., & Dodson, P. M. (2011) · Eye · doi:10.1038/eye.2011.62 · Cited by 75
Landman, G. W. D., de Bock, G. H., van Hateren, K. J. J., van Dijk, P. R., Groenier, K. H., Gans, R. O. B., Houweling, S. T., Bilo, H. J. G., & Kleefstra, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0082880 · Cited by 75
Farrokhi, F., Klindukhova, O., Chandra, P., Peng, L., Smiley, D. D., Newton, C. A., Pasquel, F. J., Fereira, M. E., & Umpierrez, G. E. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600505 · Cited by 73
Kong, A. P. S., Yang, X., Luk, A. O. Y., Ronald, C. W., So, W. Y., Ozaki, R., Ting, R. Z. W., Cheung, K. K.-T., Ho, C. S., Chan, M. H. M., et al. (2014) · Diabetes Care · doi:10.2337/dc13-2507 · Cited by 73
Nguyen, T. N., Harris, K., Woodward, M., Chalmers, J., Cooper, M., Hamet, P., Harrap, S., Heller, S., MacMahon, S., Mancia, G., et al. (2021) · Diabetes Care · doi:10.2337/dc20-2664 · Cited by 72
Self-citationSevere Hypoglycemia and Cardiovascular or All-Cause Mortality in Patients with Type 2 Diabetes
Cha, S., Yun, J., Lim, T., Hwang, S., Yim, E.-J., Song, K., Yoo, K., Park, Y., Ahn, Y., & Ko, S. (2016) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2016.40.3.202 · Cited by 73
Dysregulated cellular metabolism in atherosclerosis: mediators and therapeutic opportunities
Stroope, C., Nettersheim, F. S., Coon, B. G., Finney, A. C., Schwartz, M. A., Ley, K. F., Rom, O., & Yurdagul, A. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01015-w · Cited by 74
Khunti, K., Alsifri, S., Aronson, R., Cigrovski Berković, M., Enters-Weijnen, C., Forsén, T., Galstyan, G., Geelhoed-Duijvestijn, P., Goldfracht, M., Gydesen, H., et al. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.05.004 · Cited by 71
Morgan, C. L., Mukherjee, J., Jenkins‐Jones, S., Holden, S. E., & Currie, C. J. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12302 · Cited by 72
Effects of glucose-lowering agents on vascular outcomes in type 2 diabetes: A critical reappraisal
Scheen, A. J., & Charbonnel, B. H. (2014) · Diabetes & Metabolism · doi:10.1016/j.diabet.2014.03.004 · Cited by 71
The Kidney in Type 2 Diabetes Therapy
Heerspink, H. J. L., & de Zeeuw, D. (2011) · The Review of Diabetic Studies · doi:10.1900/rds.2011.8.392 · Cited by 71
Segar, M. W., Patel, K. V., Vaduganathan, M., Caughey, M. C., Butler, J., Fonarow, G. C., Grodin, J. L., McGuire, D. K., & Pandey, A. (2020) · Diabetes Care · doi:10.2337/dc19-2541 · Cited by 70
Hypoglycemia Rates with Basal Insulin Analogs
Little, S. A., Shaw, J., & Home, P. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0022 · Cited by 70
Mattishent, K., & Loke, Y. K. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.571568 · Cited by 69
Coronary Artery Disease and Diabetes Mellitus
Aronson, D., & Edelman, E. R. (2015) · Heart Failure Clinics · doi:10.1016/j.hfc.2015.08.010 · Cited by 69
van Meijel, L. A., de Vegt, F., Abbink, E. J., Rutters, F., Schram, M. T., van der Klauw, M. M., Wolffenbuttel, B. H. R., Siegelaar, S. E., DeVries, J. H., Sijbrands, E. J. G., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000935 · Cited by 70
Recent HbA1c Values and Mortality Risk in Type 2 Diabetes. Population-Based Case-Control Study
Nicholas, J. M., Charlton, J., Dregan, A., & Gulliford, M. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068008 · Cited by 68
Hemmingsen, B., Lund, S. S., Gluud, C. N., Vaag, A. A., Almdal, T., Hemmingsen, C., & Wetterslev, J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008143.pub2 · Cited by 69
RetractedGoto, A., Goto, M., Terauchi, Y., Yamaguchi, N., & Noda, M. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002875 · Cited by 67
Chiang, J., Jani, B., Mair, F. S., Nicholl, B. I., Furler, J., O'Neal, D. N., Jenkins, A. J., Condron, P., & Manski-Nankervis, J.-A. E. (2018) · PLoS ONE · doi:10.1371/journal.pone.0209585 · Cited by 67
Bianchi, C., & Prato, S. D. (2011) · The Review of Diabetic Studies · doi:10.1900/rds.2011.8.432 · Cited by 67
Metabolic Syndrome and Cardiometabolic Risk Factors
Papakonstantinou, E., Lambadiari, V., Dimitriadis, G., & Zampelas, A. (2014) · Current Vascular Pharmacology · doi:10.2174/15701611113116660176 · Cited by 67
Prolonged Prothrombotic Effects of Antecedent Hypoglycemia in Individuals With Type 2 Diabetes
Chow, E., Iqbal, A., Walkinshaw, E., Phoenix, F. A., Macdonald, I. A., Storey, R. F., Ajjan, R., & Heller, S. R. (2018) · Diabetes Care · doi:10.2337/dc18-0050 · Cited by 67
Self-citationS2k-Leitlinie Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Alter
Bahrmann, A., Bahrmann, P., Baumann, J., Bauer, J. M., Brückel, E., Dreyer, M., Freitag, M., Friedl, A., Gölz, S., Grundke, S., et al. (2018) · Diabetologie und Stoffwechsel · doi:10.1055/a-0666-0820 · Cited by 66
Lu, C., Shen, H.-N., Hu, S. C., Wang, J., & Li, C. (2016) · Diabetes Care · doi:10.2337/dc15-2418 · Cited by 66
Roussel, R., Steg, P. G., Mohammedi, K., Marre, M., & Potier, L. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13033 · Cited by 66
Self-citationStandl, E., Stevens, S. R., Lokhnygina, Y., Bethel, M. A., Buse, J. B., Gustavson, S. M., Maggioni, A. P., Mentz, R. J., Hernandez, A. F., & Holman, R. R. (2020) · Diabetes Care · doi:10.2337/dc19-1079 · Cited by 65
Chronic Kidney Disease in the Elderly
Maw, T. T., & Fried, L. F. (2013) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2013.05.003 · Cited by 67
Chen, M., Zhu, B., Chen, D., Hu, X., Xu, X., Shen, W., Hu, C., Li, J., & Qu, S. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.04.004 · Cited by 67
Hypoglycemia Associated With Hospitalization and Adverse Events in Older People
Majumdar, S. R., Hemmelgarn, B. R., Lin, M., McBrien, K., Manns, B., & Tonelli, M. A. (2013) · Diabetes Care · doi:10.2337/dc13-0523 · Cited by 66
Dipeptidyl Peptidase-4 Inhibitors: 3 Years of Experience
Derosa, G., & Maffioli, P. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0204 · Cited by 64
Tschöpe, D., Bramlage, P., Binz, C., Krekler, M., Deeg, E., & Gitt, A. K. (2012) · BMC Endocrine Disorders · doi:10.1186/1472-6823-12-23 · Cited by 64
Cardiovascular Disease in Diabetes: Where Does Glucose Fit In?
Reusch, J. E. B., & Wang, C. C. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-3011 · Cited by 66
Chow, E., Bernjak, A., Walkinshaw, E., Lubina-Solomon, A., Freeman, J., Macdonald, I. A., Sheridan, P. J., & Heller, S. R. (2017) · Diabetes · doi:10.2337/db16-1310 · Cited by 63
Self-citationGlucocorticoid-Induced Hyperglycemia: A Neglected Problem
Cho, J.-H., & Suh, S. (2024) · Endocrinology and Metabolism · doi:10.3803/enm.2024.1951 · Cited by 63
Chew, B., Ghazali, S. S., Ismail, M., Haniff, J., & Bujang, M. A. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2013.02.017 · Cited by 64
Rooijackers, H. M. M., Wiegers, E. C., Tack, C. J., van der Graaf, M., & de Galan, B. E. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2079-8 · Cited by 66
Uncovering undetected hypoglycemic events
Unger, J. (2012) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s29367 · Cited by 62
Li, Y., Hu, Y., Ley, S. H., Rajpathak, S. N., & Hu, F. B. (2014) · Diabetes Care · doi:10.2337/dc14-1306 · Cited by 65
Getting Under the Skin of Clinical Inertia in Insulin Initiation
Ratanawongsa, N., Crosson, J. C., Schillinger, D., Karter, A. J., Saha, C., & Marrero, D. G. (2012) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721711432649 · Cited by 63
Is hypoglycemia fear independently associated with health-related quality of life?
Shi, L., Shao, H., Zhao, Y., & Thomas, N. A. (2014) · Health and Quality of Life Outcomes · doi:10.1186/s12955-014-0167-3 · Cited by 62
Schloot, N. C., Haupt, A., Schütt, M., Badenhoop, K. W. J., Laimer, M. W., Nicolay, C., Reaney, M. D., Fink, K., & Holl, R. W. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2722 · Cited by 62
Rogers, S. C., Zhang, X., Azhar, G., Luo, S., & Wei, J. Y. (2013) · The Journals of Gerontology Series A · doi:10.1093/gerona/glt033 · Cited by 62
McCoy, R. G., Houten, H. K. V., Ross, J. S., Montori, V. M., & Shah, N. D. (2015) · BMJ · doi:10.1136/bmj.h6138 · Cited by 63
Low HbA1c and Increased Mortality Risk-is Frailty a Confounding Factor?
Abdelhafiz, A. H., & Sinclair, A. J. (2015) · Aging and Disease · doi:10.14336/ad.2014.1022 · Cited by 64
Prediction and Prevention of Treatment-Related Inpatient Hypoglycemia
Elliott, M., Schafers, S. J., McGill, J. B., & Tobin, G. S. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600213 · Cited by 63
Li, J., Albajrami, O., Zhuo, M., Hawley, C. E., & Paik, J. M. (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02690320 · Cited by 61
Parving, H. H., Brenner, B. M., McMurray, J. J. V., de Zeeuw, D., Haffner, S. M., Solomon, S. D., Chaturvedi, N., Persson, F., Nicolaides, M., Richard, A., et al. (2012) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320311434818 · Cited by 60
Monnier, L., Wojtusciszyn, A., Molinari, N., Colette, C., Renard, É., & Owens, D. R. (2020) · Diabetes Care · doi:10.2337/dc19-1549 · Cited by 62
Peña, A. S., Couper, J., Harrington, J., Gent, R. J., Fairchild, J. M., Tham, E., & Baghurst, P. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0229 · Cited by 60
Nursing home patients with diabetes: prevalence, drug treatment and glycemic control
Andreassen, L. M., Sandberg, S., Kristensen, G. B. B., Sølvik, U. Ø., & Kjome, R. L. S. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.04.012 · Cited by 60
Hypoglycemia and risk of vascular events and mortality: a systematic review and meta-analysis
Yeh, J. S., Sung, S., Huang, H.-M., Yang, H.-L., You, L., Chuang, S., Huang, P.-C., Hsu, P., Cheng, H., & Chen, C. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0803-3 · Cited by 61
Bloomfield, H. E., Greer, N. L., Newman, D. R., MacDonald, R. H., Carlyle, M. H., FITZGERALD, P. J., Rutks, I. R., & Wilt, T. J. (2012) · Cited by 59
Monnier, L., Colette, C., & Owens, D. R. (2021) · Diabetes & Metabolism · doi:10.1016/j.diabet.2021.101225 · Cited by 61
Efficacy and safety of insulin in type 2 diabetes: meta-analysis of randomised controlled trials
Erpeldinger, S., Rehman, M. B., Berkhout, C., Pigache, C., Zerbib, Y., Regnault, F., Guérin, É., Supper, I., Cornu, C., Kassaï, B., et al. (2016) · BMC Endocrine Disorders · doi:10.1186/s12902-016-0120-z · Cited by 60
Prospective Study of Fasting Blood Glucose and Intracerebral Hemorrhagic Risk
Jin, C., Li, G., Rexrode, K. M., Gurol, M. E., Yuan, X., Hui, Y., Ruan, C., Vaidya, A., Wang, Y., Wu, S., et al. (2017) · Stroke · doi:10.1161/strokeaha.117.019189 · Cited by 60
Iqbal, A., & Heller, S. R. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.06.004 · Cited by 60
Self-citationHu, Y., Wen, X., Wang, F., Yang, D., Liu, S., Li, P., & Xu, J. (2019) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x18776823 · Cited by 57
Wang, J., Geiss, L. S., Williams, D. E., & Gregg, E. W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134917 · Cited by 59
Heller, S. R., Bergenstal, R. M., White, W. B., Kupfer, S., Bakris, G. L., Cushman, W. C., Mehta, C. R., Nissen, S. E., Wilson, C., Zannad, F. M., et al. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12871 · Cited by 57
Self-citationColagiuri, S., Matthews, D. R., Leiter, L. A., Chan, S. P., Sesti, G., & Marre, M. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.05.028 · Cited by 59
Self-citationInsulin–Heart Axis: Bridging Physiology to Insulin Resistance
Caturano, A., Galiero, R., Vetrano, E., Sardu, C., Rinaldi, L., Russo, V., Monda, M., Marfella, R., & Sasso, F. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158369 · Cited by 57
Jensen, M. H., Dethlefsen, C., Vestergaard, P., & Hejlesen, O. K. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819868727 · Cited by 56
Garber, A. J., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bloomgarden, Z. T., Bush, M. A., Dagogo-Jack, S. E., Davidson, M., EINHORN, D. F., Garber, J. R., et al. (2015) · Endocrine Practice · doi:10.4158/ep151063.cs · Cited by 55
Cao, B., Guo, Z., Li, D.-T., Zhao, L.-Y., Wang, Z., Gao, Y.-B., & Wang, Y. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02610-1 · Cited by 57
Elwen, F. R., Westwood, A. C., Clapham, L., Bottomley, M. J., Heller, S. R., James, C., Abbas, A., Baxter, P. D., & Ajjan, R. (2015) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2015-000094 · Cited by 55
Self-citationBacchi, E., Negri, C., Trombetta, M., Zanolin, M. E., Lanza, M., Bonora, E., & Moghetti, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049937 · Cited by 57
Approach to diabetes management in patients with CVD
Lathief, S., & Inzucchi, S. E. (2015) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2015.05.005 · Cited by 55
Recent advances in managing and understanding diabetic nephropathy
Tang, S. C. W., Chan, G. C. W., & Lai, K. N. (2016) · F1000Research · doi:10.12688/f1000research.7693.1 · Cited by 56
Klimontov, V. V., & Myakina, N. E. (2016) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2016.08.023 · Cited by 56
Nunes, A. P., Iglay, K., Radican, L., Engel, S. S., Yang, H. J., Doherty, M. C., & Dore, D. D. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13000 · Cited by 56
A1C targets should be personalized to maximize benefits while limiting risks
Riddle, M. C., Gerstein, H. C., Holman, R. R., Inzucchi, S. E., Zinman, B., Zoungas, S., & Cefalu, W. T. (2018) · Diabetes Care · doi:10.2337/dci18-0018 · Cited by 54
Self-citationSeidu, S., Cos, X., Brunton, S., Harris, S. B., Jansson, S. P. O., Mata‐Cases, M., Neijens, A. M. J., Topsever, P., & Khunti, K. (2022) · Primary care diabetes · doi:10.1016/j.pcd.2022.02.002 · Cited by 60
Insulin treatment for type 2 diabetes: When to start, which to use
Hamaty, M. (2011) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.78a.10051 · Cited by 54
Wagner, J. A., Tennen, H. A., & Wolpert, H. A. (2012) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31825769ac · Cited by 54
Zou, L., Zhu-Mauldin, X., Marchase, R. B., Paterson, A. J., Liu, J., Yang, Q., & Chatham, J. C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.393207 · Cited by 54
Glucose Control and Vascular Outcomes in Type 2 Diabetes: Is the Picture Clear?
Giorgino, F., Home, P., & Tuomilehto, J. O. (2016) · Diabetes Care · doi:10.2337/dcs15-3023 · Cited by 55
Karter, A. J., Lipska, K. J., O’Connor, P. J., Liu, J. Y., Moffet, H. H., Schroeder, E. B., Lawrence, J. M., Nichols, G. A., Newton, K. M., Pathak, R. D., et al. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.02.009 · Cited by 53
Sulfonylureas as Initial Treatment for Type 2 Diabetes and the Risk of Severe Hypoglycemia
Yu, O. H. Y., Azoulay, L., Yin, H., Filion, K. B., & Suissa, S. (2017) · The American Journal of Medicine · doi:10.1016/j.amjmed.2017.09.044 · Cited by 54
Trajectories of fasting plasma glucose variability and mortality in type 2 diabetes
Lee, C.-L., Sheu, W. H., Lee, I., Lin, S., Liang, W., Wang, J., & Li, Y. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.09.001 · Cited by 53
Hypoglycemia From a Cardiologist's Perspective
Sanon, V. P., Sanon, S., Kanakia, R., Hu, Y., Araj, F., OLIVEROS, R. A., & CHILTON, R. J. (2014) · Clinical Cardiology · doi:10.1002/clc.22288 · Cited by 52
Kikuchi, Y., Iwase, M., Fujii, H., Ohkuma, T., Kaizu, S., Ide, H., Jodai, T., Idewaki, Y., Nakamura, U., & Kitazono, T. (2015) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2014-000063 · Cited by 56
Ceriello, A., Novials, A., Ortega, E., Pujadas, G., Sala, L. L., Testa, R., Bonfigli, A. R., & Genovese, S. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.05.003 · Cited by 52
Mogensen, U. M., Andersson, C., Fosbøl, E. L., Schramm, T. K., Vaag, A. A., Scheller, N. M., Torp-Pedersen, C. T., Gislason, G., & Køber, L. (2014) · Diabetologia · doi:10.1007/s00125-014-3372-z · Cited by 52
Zhao, F. L., Deng, J., Xu, X., Cao, F., Lu, K., Li, D., Cheng, X., Wang, X., & Zhao, Y. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1203-8 · Cited by 52
Cai, L., Cai, Y., Lu, Z., Zhang, Y., & Liu, P. (2011) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2011.01323.x · Cited by 51
Individualizing Targets and Tactics for High-Risk Patients With Type 2 Diabetes
Riddle, M. C., & Karl, D. M. (2012) · Diabetes Care · doi:10.2337/dc12-0650 · Cited by 51
Melmer, A., & Laimer, M. W. (2016) · Endocrine development · doi:10.1159/000439364 · Cited by 53
Metadata
- Authors
- Zoungas, S., Patel, A., Chalmers, J., de Galan, B. E., Li, Q., Billot, L., Woodward, M., Ninomiya, T., Neal, B., MacMahon, S., Grobbee, D. E., Kengne, A. P., Marre, M., & Heller, S.
- Affiliations
- The University of Sydney (AU)
- University Medical Center Utrecht (NL)
- Hôpital Bichat-Claude-Bernard (FR)
- National Health Service (GB)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-10-07
- Volume
- 363
- Issue
- 15
- Pages
- 1410-1418
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2097995302
- Semantic Scholar
- b73e51368b0f6c3d0c425e6670188db927bc8b09
- Cited by
- 1,471
- References
- 31
- Citations by year
- 2026: 33 · 2025: 49 · 2024: 64 · 2023: 60 · 2022: 66 · 2021: 103 · 2020: 119 · 2019: 99 · 2018: 113 · 2017: 103 · 2016: 107 · 2015: 147 · 2014: 106 · 2013: 98 · 2012: 103
- FWCI
- 71.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- severe hypoglycemia, type 2 diabetes, tight glycemic control, macrovascular events, cardiovascular mortality, all-cause mortality, adverse clinical outcomes, diabetes complications, UKPDS
- MeSH terms
- Blood Glucose, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Gliclazide, Humans, Hypoglycemia, Hypoglycemic Agents, Male, Middle Aged, Risk Factors, Vascular Diseases, Proportional Hazards Models, Microvessels
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
